Blue finger syndrome – case report  by Ferreira, Joana et al.
Angiol Cir Vasc. 2016;12(2):97--100
www.elsevier.pt/acv
ANGIOLOGIA
E CIRURGIA  VASCULAR
CASE REPORT
Blue  ﬁnger  syndrome  --  case  report
Joana Ferreiraa,∗, Rui Ramosb, Pedro Sousab
a Angiologia  e  Cirurgia  Vascular,  Centro  Hospitalar  de  Trás-os-Montes  e  Alto  Douro/EPE,  Portugal
b Radiologia,  Centro  Hospitalar  de  Trás-os-Montes  e  Alto  Douro/EPE,  Portugal
Available  online  31  March  2016
KEYWORDS
Blue  ﬁnger  syndrome;
Endovascular
treatment;
Right  subclavian
artery
Abstract  Blue  Finger  Syndrome  is  a  manifestation  of  atheromatous  embolization  at  the  upper
limb. It’s  a  rare  pathology,  with  risk  of  recurrence  and  tissue  lose,  which  could  be  particular
troublesome  at  the  upper  limb.  The  authors  present  a  case  of  a  Blue  Finger  Syndrome  secondary
to an  atherosclerotic  plaque  in  the  right  subclavian  artery  (which  is  an  unusual  location),  cor-
rected with  a  stent.  The  majority  of  authors  consider  that  the  embolization  source  should  be
corrected.  If  it  is  not  corrected,  there  is  a  risk  of  re-embolization,  which  may  threaten  the  limb
viability.  Endovascular  treatment  is  safe  and  efﬁcacious.  Direct  stenting,  especially  with  closed
stents design  appear  to  be  the  safest  technique  to  trap  thrombi  and  prevent  distal  thrombus
embolization.
© 2016  Published  by  Elsevier  Espan˜a,  S.L.U.  on  behalf  of  Sociedade  Portuguesa  de  Angiolo-
gia e  Cirurgia  Vascular.  This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
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Blue  ﬁnger  syndrome  --  a  propósito  de  um  caso  clínico
Resumo  O  Blue  Finger  Syndrome  é  uma  manifestac¸ão  da  embolizac¸ão  distal  nos  membros
superiores.  É  uma  patologia  rara,  com  risco  de  recorrência  e  de  perda  tecidular,  o  que  poderá  ser
particularmente  grave  no  membro  superior.  Os  autores  apresentam  um  caso  de  um  Blue  Finger
Syndrome, secundário  a  uma  placa  de  aterosclerose  na  artéria  subclávia  direita  (localizac¸ão  esta
particularmente  rara)  corrigida  através  da  colocac¸ão  de  stent.  A  maioria  dos  autores  considera
que a  fonte  embólica  deverá  ser  corrigida.  A  sua  não  correc¸ão  poderá  signiﬁcar  a  recorrência
do fenómeno,  com  risco  de  perda  de  membro.  O  tratamento  endovascular  tem-se  mostrado
seguro e  eﬁcaz.  A  colocac¸ão  de  stent  (em  particular  de  malhas  fechadas)  aprisiona  a  placa  de
aterosclerose,  prevenindo  a  embolizac¸ão  distal.
© 2016  Publicado  por  Elsevier  Espan˜a,  S.L.U.  em  nome  de  Sociedade  Portuguesa  de  Angiolo-
gia e  Cirurgia  Vascular.  Este e´  um  artigo  Open  Access  sob  uma  licenc¸a  CC  BY-NC-ND  (http://
creativecommons.org/licenses/by-nc-nd/4.0/). Presented at the XV Congress of the SPACV 11 June 13, 2015.
∗ Corresponding author at: Rua do Bolhão no. 268, 4505-314 Fiães VFR,
E-mail address: joana222@hotmail.com (J. Ferreira).
http://dx.doi.org/10.1016/j.ancv.2016.01.007
1646-706X/© 2016 Published by Elsevier Espan˜a, S.L.U. on behalf of Soci
access article under the CC BY-NC-ND license (http://creativecommons. Portugal. Tel.: +351 962 958 421.
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Figure  2  CT  scan  showing  the  atherosclerotic  plaque  at  the
right subclavian  artery.8  
ntroduction
lue  ﬁnger  syndrome  (BFS)  describes  acute  digital  cyanosis
econdary  to  microembolism  from  a  proximal  atheroma-
ous  source.1--3 Due  to  its  lethality,  the  diagnosis  should  be
romptly  established  and  an  aggressive  treatment  imme-
iately  initiated,  in  order  to  prevent  recurrences.1--3 The
uthors  present  a  case  of  a  BFS  secondary  to  an  atheroscle-
otic  plaque  in  the  right  subclavian  artery.
ase report
ale,  79  years  old,  smoker,  was  admitted  with  bluish  dis-
oloration  of  the  distal  phalanges  in  the  right  hand  (Fig.  1).
e  denies  any  history  of  trauma,  cold  exposition,  previous
pisodes  of  ﬁngers  color  changes,  weight  loose  and  other
onstitutional  symptoms.  The  humeral,  radial  and  cubital
ulses  were  present  bilaterally  with  normal  characteris-
ics.  No  murmurs  or  bruits  were  audible.  No  neurologic  sign
r  symptoms  were  recorded.  There  were  no  differences
n  the  arterial  pressure  between  the  right  and  left  upper
imbs.  He  underwent  a  Doppler  ultrasound  which  revealed
n  atherosclerotic  plaque  in  the  right  subclavian  artery.  This
esult  was  conﬁrmed  with  CT  scan  (Fig.  2).  The  CT  scan
id  not  show  any  skeletal  or  muscle  anomaly.  He  also  per-
ormed  an  electrocardiogram  and  posteriorly  a  transthoracic
nd  transesophageal  echocardiograms  which  were  normal.
o  hematologic  or  prothrombotic  abnormality  was  found.
he  patient  was  submitted  to  endovascular  repair.  Under
ocal  anesthesia,  using  a  right  humeral  approach,  a  7Fr
oston  Scientiﬁc  sheath,  with  11  cm  length  was  used  in  the
ight  humeral  artery.  The  plaque  was  crossed  by  a  0.035
 hydrophilic  guide  wire,  then  using  a  0.035  stiff  guide
ire  a  self-expandable  stent  Cordis  S.M.A.R.T.®CONTROL®
9  mm  ×  30  mm)  was  deployed  (Figs.  3  and  4).  The  stent  was
osteriorly  dilated.  The  patient  was  on  double  antiplatelet
herapy  during  two  months  and  chronically  on  aspirin  and
tatin.  Six  months  of  the  follow-up  the  patient  is  asymp-
omatic,  without  recurrences  and  the  CT  scan  performed
howed  that  the  stent  is  patent  without  fractures  (Fig.  5).
Figure  1  Patient  with  cyanotic  ﬁngers  at  the  right  hand.
Figure  3  Angiography  demonstrating  an  irregular  atheroscle-
rotic  plaque  at  the  right  subclavian  artery.
Figure  4  Stenting  at  the  right  subclavian  artery.
Blue  ﬁnger  syndrome-case  report  
Figure  5  CT  scan,  at  six  months  after  stent  deployment  at
the right  subclavian  artery.
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declare  that  no  patient  data  appear  in  this  article.
Conﬂicts of interestDiscussion
BFS  is  a  manifestation  of  atheromatous  embolization  at  the
upper  limb.1,2 The  embolization  source  could  be  central
(which  was  excluded  in  this  case)  or  peripheral  (which  is
the  consistent  hypothesis  in  this  report).  Embolization  can
occur  spontaneously,  as  in  this  case,  or  after  an  invasive  vas-
cular  procedure.2,3 The  majority  of  plaques  associated  with
embolization  is  localized  at  the  abdominal  aorta  and  the
iliofemoral  arteries.2 The  subclavian  artery,  particularly  the
right  subclavian  artery,  is  a  rare  source  of  embolization.1,2
Beside  this,  the  embolization  plaque  is  typically  located
at  the  ostium.4 However,  in  this  case,  the  lesion  was  at
the  second  part  of  the  subclavian  artery,  which  is  quite
unusual.
The  underlying  atheromatous  lesion  can  be  recognized
as  an  area  of  intimal  irregularity,  which  in  some  occasions
may  not,  be  hemodynamically  signiﬁcant.1 So,  the  patient
may  not  complain  of  arm  claudication  and  the  only  clinical
manifestation  of  the  atherosclerosis  plaque  could  be  skin
changes.1 In  this  particular  case,  the  lesion  was  not  hemo-
dynamically  signiﬁcant  (there  were  no  differences  in  the
arterial  pressure  in  the  upper  limbs,  neither  claudication
complaints).  The  patient  just  complained  about  bluish  dis-
coloration  in  the  distal  phalanges.  This  clinical  presentation
could  be  explained  by  the  morphologic  characteristics  of
the  atherosclerotic  plaque  which  is  irregular  and  hypodense,
with  embolization  risk.
Beyond  this,  skin  ﬁndings,  in  the  BFS  includes  livedo
reticularis,  gangrene  and  ulceration.2
Skin  changes  are  a  reﬂection  of  microvascular  ischemia,
due  to  embolization.  The  embolic  material  occludes  the
small  arteries  and  arterioles  rather  than  the  large  superﬁcial
arteries,  so  distal  pulses  remain  frequently  palpable.2
Apart  from  this,  clinical  manifestations  of  embolization
include  constitutional  symptoms  (fever,  anorexia,  weight
loss,  fatigue  and  myalgias),  signs  of  systemic  inﬂammation
(anemia,  thrombocytopenia,  leukocytosis,  high  erythrocyte T99
edimentation  rate,  elevated  levels  of  C-reactive  protein),
hich  were  not  present  in  the  case.2
As  BFS  is  a  manifestation  of  atherosclerosis,  patients
hould  be  submitted  to  an  aggressive  medical  therapy  that
ncludes  smoking  cessation,  life  style  modiﬁcation,  blood
ressure  and  diabetes  control,  hyperlipidemia  manage-
ent,  aspirin,  -blockers,  angiotensin  converting  enzyme
nhibitors  and  statins.2
The  treatment  with  thrombolytic  or  anticoagulation
s  not  consensual,  because  they  can  precipitate  distal
mbolization.2
In  addition  to  these  measures,  it  seems  reasonable  to
orrect  the  source  of  embolism,  although  there  are  no
andomized  trials  comparing  the  medical  treatment  with
nvasive  interventions  (surgically  or  percutaneously)  to  elim-
nate  the  cause  of  embolism.1--3 Although,  if  the  embolic
ource  is  not  corrected,  there  is  a  risk  of  re-embolization,
hich  may  threaten  the  limb  viability.1,2 The  correction
ould  be  surgically  or  percutaneously.1,2
In  this  case  reported,  we  decide  to  perform  it  percuta-
eously  due  to  its  less  invasiveness  when  comparing  to  the
urgical  treatment.
Direct  stenting,  especially  with  closed  stents  design
ppear  to  be  the  safest  technique  to  trap  thrombi  and
revent  distal  thrombus  migration.4 It  also  stimulate  the  for-
ation  of  a  stable  neointima  and  establish  a  normal  ﬂow.1
n  this  case  we  deployed  the  stent  in  the  irregular  and
ypodense  atherosclerotic  plaque.  We  used  a right  brachial
pproach,  which  provides  a  greater  stability  and  also  a
traightforward  route  which  aids  stent  deployment.
Some  authors  suggest  the  use  of  a  balloon  to  protect
he  vertebral  artery  and  avoiding  embolization  or  occlusion,
hich  is  really  useful  if  the  atherosclerosis  lesion  is  close  to
he  origin  of  the  vertebral  artery.1 In  this  particular  case,
e  did  not  use  it  due  to  the  location  of  the  plaque,  which
as  not  near  the  vertebral  artery  origin.
Surgery  to  correct  the  proximal  underlying  source
ncludes  subclavian  carotid  transposition  and  carotid  sub-
lavian  bypass  with  proximal  ligation.1 This  carry  a
erioperative  death  rate  of  0--2%  and  a  stroke  rate  of
.0--3.0%.1 In  addition,  1.0--2.0%  of  grafts  become  infected.1
ther  complications  reported  are  phrenic  nerve  injury,  tho-
acic  duct  laceration  and  Horners  syndrome.1
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